H2 receptor antagonists
Pro Research Analysisby 
Searched over 200M research papers
H2 Receptor Antagonists: Mechanism and Clinical Use
H2 receptor antagonists are a class of drugs that block histamine H2 receptors in the stomach, leading to reduced gastric acid secretion. They are primarily used to treat conditions like peptic ulcer disease, Zollinger-Ellison syndrome, and gastric hyperacidity. Common drugs in this class include cimetidine, ranitidine, famotidine, and nizatidine, each with varying potency and duration of action. Famotidine is noted as the most potent and selective among them, with a longer duration and fewer drug interactions compared to cimetidine and ranitidine Ivey1980Siepler1978Schunack1987+1 MORE.
Efficacy in Treating Acid-Related Disorders
H2 receptor antagonists have revolutionized the management of peptic ulcer disease and related conditions by effectively reducing gastric acid secretion. Cimetidine, in particular, has shown strong efficacy in treating duodenal ulcers and shows promise for Zollinger-Ellison syndrome and gastric ulceration. These drugs are also used for preventing gastrointestinal bleeding and treating peptic esophagitis Ivey1980Siepler1978Malagelada1978.
Safety Profile and Adverse Effects
H2 receptor antagonists are generally well tolerated, with a low incidence of side effects. Minor side effects such as diarrhea, headache, dizziness, constipation, and reversible central nervous system effects (like confusion and drowsiness) are infrequent and usually mild. Serious adverse reactions, including cardiovascular complications and bone marrow effects, are extremely rare. Famotidine, in particular, has a very low rate of side effects and does not cause irreversible adverse effects Pension1986Schunack1987Hinrichsen1992.
Drug Interactions and Metabolism
Some H2 receptor antagonists, especially cimetidine, can inhibit the hepatic enzyme cytochrome P450, leading to increased plasma concentrations of other drugs metabolized by this pathway, such as oral anticoagulants, beta-blockers, anticonvulsants, benzodiazepines, and xanthines. Famotidine, however, does not interact with cytochrome P450 and thus has fewer drug interactions. Additionally, these drugs can alter the absorption and excretion of other medications due to their effects on gastric secretion and renal tubular transport Pension1986Schunack1987.
Tolerance and Receptor Regulation
Tolerance to the acid-inhibitory effects of H2 receptor antagonists can develop after one to two weeks of continuous use, with a decrease in efficacy observed over time. This tolerance is more pronounced with multiple daily dosing regimens. Mechanistically, some H2 antagonists like cimetidine and ranitidine act as inverse agonists, leading to upregulation of H2 receptors, which may explain the development of tolerance during prolonged therapy Smit1996Wilder-Smith1990.
Additional Effects and Considerations
H2 receptor antagonists can influence the first-pass metabolism of ethanol, potentially increasing blood alcohol concentrations under certain conditions. This effect is most notable with cimetidine but has also been observed with other drugs in this class . Cardiovascular side effects are rare but have been reported, particularly with rapid intravenous administration Pension1986Hinrichsen1992.
Conclusion
H2 receptor antagonists are effective, widely used, and generally safe medications for managing acid-related gastrointestinal disorders. While minor side effects and drug interactions can occur, especially with cimetidine, newer agents like famotidine offer improved safety and potency. Tolerance and receptor upregulation are important considerations for long-term therapy, and ongoing research continues to clarify their broader effects and optimal use in clinical practice Ivey1980Siepler1978Pension1986+6 MORE.
Sources and full results
Most relevant research papers on this topic